NCT04583449 is a NA clinical trial of Mental imagery in Viral Infection, sponsored by University of East London.

Who is sponsoring NCT04583449?

NCT04583449 is sponsored by University of East London.

What drugs are being tested in NCT04583449?

Interventions in NCT04583449: Mental imagery.

What condition does NCT04583449 study?

NCT04583449 studies Viral Infection, Covid19.

Is NCT04583449 still recruiting?

NCT04583449 is currently status unknown. Last updated 12 October 2020.

Last reviewed 2020-10-12 · How we verify

NCT04583449

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mental Imagery to Increase Face Covering Use in UK-based Public Places During the COVID-19 Pandemic

Status unknown NA Last updated 12 October 2020

What this trial tests

NA trial testing Mental imagery in Viral Infection in 250 participants. Status unknown.

Timeline

19 August 2020

Primary endpoint
1 December 2020

1 December 2020

Quick facts

Lead sponsor	University of East London
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	factorial
Masking	single
Primary purpose	prevention
Enrollment	250
Start date	19 August 2020
Primary completion	1 December 2020
Estimated completion	1 December 2020
Sites	1 location across United Kingdom

Drugs / interventions tested

Mental imagery

Conditions studied

Viral Infection — all drugs for Viral Infection →
Covid19 — all drugs for Covid19 →

Sponsor

University of East London

Who can join

18 and older, any sex, with Viral Infection or Covid19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Wearing face coverings in enclosed public spaces is a key public health measure to limit viral spread during the 2020 Covid-19 pandemic. Health psychologists are interested in developing interventions that can increase the likelihood of health-adherent and protective behaviours being consistently undertaken at a general population level. Mental imagery interventions are one way in which behavioural scientists and health psychologists try to encourage behaviour change. Mental imagery involves thinking about, and then writing about, anticipated positive outcomes or key practical requirements of a defined health-related action (e.g. 'moderate alcohol consumption'; 'engaging in regular physical activity'). For this project, the investigators are exploring a mental imagery intervention created to encourage regular and consistent wearing of face coverings in public places where this is currently required in the UK. The investigators will test whether engaging in a mental imagery exercise results in any improvement in wearing a face covering (or intention to wear a face covering) one month later relative to reading a public health message about face coverings. In addition, the investigators will explore belief-based and personality-related factors that might make a difference to the effectiveness of the mental imagery intervention.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Mental imagery interventions to promote face covering use among UK university students and employees during the COVID-19 pandemic: study protocol for a randomized controlled trial.
Conroy D. · · 2022 · cited 2× · PMID 35042564 · DOI 10.1186/s13063-021-05852-y
Mental Imagery Interventions to Promote Face Covering Use During the COVID-19 Pandemic: Study Protocol for a Randomized Controlled Trial.
Conroy D. · · 2021 · DOI 10.21203/rs.3.rs-350757/v1

Verify or expand the search:

Other recruiting trials for Viral Infection

Currently open trials in the same condition.

NCT06931002 — A Rhinovirus Challenge Study to Investigate Exacerbations and Immune Responses in Bronchiectasis · NA · recruiting
NCT06271655 — Rapid Diagnosis of Viral Acute Respiratory Infection to Decrease Unnecessary Antibiotic Utilization in the Emergency Dep · NA · active not recruiting
NCT05671159 — COMPArative Study of the Consequence on innaTe Immune Response du to Bacterial or Viral Infection in Patients Admitted t · NA · recruiting
NCT05246098 — REVIVe: Frailty, Rehabilitation, and Outcomes in Critically Ill Adult and Pediatric Survivors of COVID-19 or ARI · recruiting
NCT04691622 — Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts · Phase 1 · recruiting

Other University of East London trials

Trials by the same sponsor.

NCT05436613 — Transcranial Direct Current Stimulation Therapy for Bipolar Depression · NA · completed
NCT03632434 — Transcranial Direct Current Stimulation Therapy for Major Depression · NA · completed
NCT03464838 — Effects of Transcranial Direct Current Stimulation (tDCS) in Gambling Disorder · NA · unknown
NCT04273698 — What Can be Learnt From a Pilot Project Offering Brief Therapeutic Work to Parents and Infants in a Child and Adolescent · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04583449 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of East London
Last refreshed: 12 October 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04583449.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing